K&L Gates Advises Gorka Holding on Sale of Majority of Shares in DiaSys Diagnostics Systems GmbH

Global law firm K&L Gates LLP has advised Gorka Holding - GmbH on the sale of 75% of the shares in DiaSys Diagnostics Systems GmbH to Mindray Medical Netherlands B.V., an indirect subsidiary of the listed Shenzhen Mindray Bio-Medical Electronics Co., Ltd. The transaction is subject to foreign investment control clearance.

DiaSys, founded in 1991 and headquartered in Holzheim, Germany, with subsidiaries in Germany, Brazil, India, Japan and the US, develops and manufactures systems for clinical laboratories. Mindray is a provider of medical device solutions headquartered in Shenzhen, People's Republic of China. K&L Gates' advice included extensive pre-structuring of the transaction, through which the seller will retain certain subsidiaries of DiaSys.

Frankfurt partners Volker Gattringer and Boris Kläsener (both corporate/M&A) led the team that advised Gorka Holding on the transaction, with other team members including Frankfurt partners Dr. Thorsten Vormann (IP), Rainer Schmitt (tax), and Kerstin Hanke (corporate/M&A), Berlin partners Dr. Annette Mutschler-Siebert (antitrust, competition, and trade regulation), Dr. Wilhelm Hartung (corporate/M&A), Nils Neumann (labor), and Dr. Thomas Nietsch (technology transactions), as well as Washington, D.C., partner Steven F. Hill (antitrust, competition, and trade regulation), Frankfurt counsel Dr. Angelika Bartholomäi (corporate/M&A), Berlin counsel Marion Baumann (antitrust, competition, and trade regulation), and Berlin associate Alexander Rospert (antitrust, competition, and trade regulation).